APVO

0.40611.88%
ZP

Zsolt P. Harsanyi

Independent Non-Executive Chairman

Dr. Zsolt P. Harsanyi, Ph.D. has been an Independent Director of Emergent BioSolutions Inc. since August 2004 and serves as its Chairman of the Board since April 01, 2022 and served as its Lead Director. He served as the Chief Executive Officer of Exponential Biotherapies, Inc. from December 2004 to February 2011. Dr. Harsanyi served as President of Porton International plc from January 1983 to December 2004. He served as Vice President of Corporate Finance at E.F. Hutton, Inc. with responsibility for assessing and financing biotechnology companies. Dr. Harsanyi founded Dynport Vaccine Company LLC in September 1996. From 1979 to 1981, Dr. Harsanyi directed the first major assessment of biotechnology for the U.S. Congress’s Office of Technology Assessment, namely, impacts of Applied Genetics: Microorganisms, Plants and Animals. Dr. Harsanyi served as an Adviser to the President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. He has been Chairman of the Board of N-Gene Research Laboratories, Inc. since March 2011. He served as the Chairman of Exponential Biotherapies, Inc. from December 2004 to February 2011 and serves as its Director. In January 2016, Dr. Harsanyi returned to Exponential Biotherapies Inc. and serves as Chairman of the Board. He serves as a Member of Advisory Board at NouvEau Inc. He serves as a Director of N-Gene Research Laboratories, Inc. He has been an Independent Director of Aptevo Therapeutics Inc. since August 01, 2016. From 1970 to 1979, he served on the faculty of Cornell Medical College and conducted research in microbial genetics and infectious diseases. He accepted faculty appointments in both the medical and graduate divisions of Cornell University Medical College and became Director of the Genetics Training Program. Dr. Harsanyi served on the Technical and Scientific Advisory Board of BioINVENTION, Biotechnology and Telegen. He served as a Trustee of Immune Disease Institute Inc. He served on the OTA advisory panels for two Congressional assessments: Commercial Biotechnology: An International Assessment and Human Gene Therapy. Dr. Harsanayi was on the faculties of Microbiology and Genetics at Cornell Medical College. On several occasions he has been invited to testify before the U.S. Congress on the benefits of biotechnology. He was a recipient of the annual Andrew W. Mellon Teacher-Scientist Award. He has contributed chapters to several books and was the author of Genetic Prophecy: Beyond the Double Helix. Dr. Harsanyi a 1961 graduate of the Pingry School, received his B.A. from Amherst College in 1965 and his Ph.D. in genetics from the Albert Einstein College of Medicine in 1970.

Positions